CYP19A1 and polycystic ovary syndrome: In addition, the expression of one ovarian gene was dramatically increased in both strains in response to DHEA treatment, namely Cyp19. Genetic variants of the aromatase gene have been associated with the development of PCOS [47], [48], [49].